CVI Investments, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share (SLXN)

Filing Manager: CVI Investments, Inc.
Reporting Manager: CVI Investments, Inc.
Security: Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share
Symbol: SLXN
Shares outstanding: 9.32M shares
Disclosed Ownership: 457K shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Filing time: 12 May 2025, 12:12:14 UTC
Date of event: 31 Mar 2025
Previous filing: 23 Jan 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
CVI Investments, Inc.	4.9%	457K	0	457K	/s/ Brian Sopinsky	Brian Sopinsky, Secretary of Heights Capital Management, Inc.
Heights Capital Management, Inc.	4.9%	457K	0	457K	/s/ Brian Sopinsky	Brian Sopinsky, Secretary